SNSE NASDAQ
Sensei Biotherapeutics, Inc.
1W: +6.5%
1M: -30.1%
3M: -53.7%
YTD: +43.5%
1Y: +106.4%
3Y: -49.5%
5Y: -94.3%
$13.85
Last traded 2026-06-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (18)
Sensei Biotherapeutics, Inc. (NASDAQ:FTH) Stock Has Average Price Target of $56.25
Bank of America Corp DE Raises Holdings in Sensei Biotherapeutics, Inc. $FTH
Sensei Biotherapeutics, Inc. (NASDAQ:FTH) Receives $55.00 Consensus Target Price from Analysts
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Most and least shorted small-to-mid-cap stocks
Most and least shorted healthcare stocks with up to $2B market cap in May
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Receives $40.00 Consensus Target Price from Analysts
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Significant Increase in Short Interest
Most and least shorted small-to-mid-cap stocks
Most and least shorted healthcare stocks with up to $2B market cap in March
Sensei Biotherapeutics GAAP EPS of -$16.72
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Up 1,973.5% in February
Catalyst Watch: Nvidia blockbuster, JPMorgan event, and reactions to the tariff reset
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump?